CATALOG

BELGIUM WEBSITES

Domain and Website Information:

vaerd.be

Nederlands Français




About site:


Domain name - vaerd.be


Site title - Vaerd | EVENTERIOR


Go to website - Vaerd | EVENTERIOR



Words count at vaerd.be:

view - 12
private - 6
page - 5
business - 5
vaerd - 4
home - 4
contact - 4
the - 4
qode - 4
template - 3

See complete list



Site GEO location


Location Country - Belgium



Provider - Combell NV



vaerd.be GEO Location on Map



Site Logo



There is no Open Graph data at vaerd.be


Information for domain vaerd.be


IP address:

2.59.64.15


Domain name servers:


ns6.computerkliniek.com ns5.computerkliniek.be


All records:


☆ vaerd.be. 3594 IN A 2.59.64.15
☆ vaerd.be. 3594 IN MX 0 vaerd-be.mail.protection.outlook.com.
☆ vaerd.be. 3594 IN NS ns5.computerkliniek.be.
☆ vaerd.be. 3594 IN NS ns6.computerkliniek.com.
☆ vaerd.be. 3594 IN TXT "MS=ms38660505"
☆ vaerd.be. 3594 IN TXT "v=spf1 include:spf.protection.outlook.com -ip4:2.59.64.15 -all"
☆ vaerd.be. 14394 IN SOA ns5.computerkliniek.be. hostmaster.vaerd.be. 2024042200 14400 3600 1209600 86400



Whois server information for vaerd.be

%
% The WHOIS service offered by DNS Belgium and the access to the records in the DNS Belgium
% WHOIS database are provided for information purposes only. It allows
% persons to check whether a specific domain name is still available or not
% and to obtain information related to the registration records of
% existing domain names.
%
% DNS Belgium cannot, under any circumstances, be held liable where the stored
% information would prove to be incomplete or inaccurate in any sense.
%
% By submitting a query you agree not to use the information made available
% to:
% - allow, enable or otherwise support the transmission of unsolicited,
% commercial advertising or other solicitations whether via email or otherwise;
% - target advertising in any possible way;
% - to cause nuisance in any possible way to the domain name holders by sending
% messages to them (whether by automated, electronic processes capable of
% enabling high volumes or other possible means).
%
% Without prejudice to the above, it is explicitly forbidden to extract, copy
% and/or use or re-utilise in any form and by any means (electronically or
% not) the whole or a quantitatively or qualitatively substantial part
% of the contents of the WHOIS database without prior and explicit permission
% by DNS Belgium, nor in any attempt thereof, to apply automated, electronic
% processes to DNS Belgium (or its systems).
%
% You agree that any reproduction and/or transmission of data for commercial
% purposes will always be considered as the extraction of a substantial
% part of the content of the WHOIS database.
%
% By submitting the query you agree to abide by this policy and accept that
% DNS Belgium can take measures to limit the use of its whois services in order to
% protect the privacy of its registrants or the integrity of the database.
%

Domain: vaerd.be
Status: NOT AVAILABLE
Registered: Mon Dec 16 2019

Registrant:
Not shown, please visit www.dnsbelgium.be for webbased whois.

Registrar Technical Contacts:

Registrar:
Name: X-plose BVBA
Website: https://www.x-plose.be

Nameservers:
ns2.sharecom.be
ns1.sharecom.be

Keys:

Flags:

Please visit www.dnsbelgium.be for more info.



Brief facts about vaerd:

Vaccine-associated enhanced respiratory disease, or simply enhanced respiratory disease, is an adverse event where an exacerbated course of respiratory disease occurs with higher incidence in the vaccinated population than in the control group. It is a barrier against vaccine development that can lead to its failure. Immunologically, VAERD is characterized with an exaggerated Th2 response and eosinophilic pulmonary infiltrations. It may result from antibody-mediated complement activation followed by weak neutralization. Historical instances of the phenomenon were seen in vaccine candidates for respiratory syncytial virus, SARS-CoV, Middle East Respiratory Syndrome, and some influenza strains. Thus, COVID-19 vaccine clinical research involved monitoring for VAERD because the vaccine target, SARS-CoV-2, belongs to the same viral subfamily as SARS-CoV and MERS. The effect was not shown in phase III clinical trials for Tozinameran or for the Moderna vaccine.

Drug-induced diseases

Vaccination

 

© DMS 2011-